Forbion Growth Opportunities Fund I Cooperatief U.A. - 10%+ Owner at enGene Therapeutics Inc.

Issuer-level insider activity

Role
10%+ Owner
Issuer ticker
ENGN, ENGNW on Nasdaq
Identity Names, identifiers, and filing context for this profile. 1 identity field
Entity type
Company
Source evidence Original filing metadata and source links for verification. 1 source field
Source filing history
Open source filing history

No buys or sells have been reported by Forbion Growth Opportunities Fund I Cooperatief U.A. since 05 Sep 2025

Reported holdings for Forbion Growth Opportunities Fund I Cooperatief U.A. in enGene Therapeutics Inc.

Form 4 holding 10%+ Owner

enGene Holdings Inc.

Security class
Common Shares
Shares / value
3,765,932
Estimated value
$33,516,795
Report date
30 Oct 2024
Price
$8.90
Ownership
By Forbion Growth Sponsor FEAC I B.V.
Form 4 holding 10%+ Owner

enGene Holdings Inc.

Security class
Common Shares
Shares / value
3,032,430
Estimated value
$26,988,627
Report date
30 Oct 2024
Price
$8.90
Ownership
Direct

Transaction history for Forbion Growth Opportunities Fund I Cooperatief U.A. in enGene Therapeutics Inc.

Sym Class Transaction % SEC-reported value SEC-reported price Shares Shares after Date Ownership
* marks a reported price that did not pass the local price check.
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .